Zinger Key Points
- Tilray leverages its hemp and craft beer expertise to meet rising demand for alternative adult beverages in the U.S.
- Initial rollout in Texas and Louisiana signals Tilray's ambition to capture market share in the expanding THC beverage market.
- With stocks plunging, steady income is key. Tim Melvin & Ryan Faloona reveal dividend stocks and deep-value plays on April 8. Reserve your spot now.
Canadian cannabis powerhouse Tilray Brands, Inc. TLRY, announced Tuesday that it has launched a new line of hemp-derived Delta-9 THC beverages across key U.S. markets.
The drinks, set to debut in October, include a range of mocktails, seltzers and sparkling beverages crafted with premium hemp extracts. This move marks Tilray's strategic expansion into the fast-growing hemp-derived THC beverage category.
- Get Benzinga’s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter here. If you’re serious about the business, you can’t afford to miss out.
Tilray Targets Growing Cannabis Beverage Market
Tilray, already a leader in the cannabis, hemp and beverage industries, is leveraging its expertise to meet rising consumer demand for alternative adult beverages. Its new product lineup includes brands like 420 Fizz, Herb & Bloom, Fizzy Jane's and Happy Flower, each with 5mg of Delta-9 THC per can. These products will target a variety of occasions and consumer price points, appealing to diverse audiences.
Read Also: Hemp-Derived THC Beverages: Navigating Regulatory Uncertainty In A Potential $13.5B Market
Eyeing Broader Expansion In U.S.
Tilray's push into the Delta-9 THC space builds on its established presence in the hemp food and craft beer markets. As consumers explore new adult beverage options, the company aims to capture market share by offering a premium, responsibly formulated product experience.
The initial portfolio will roll out in states like Texas and Louisiana, with plans for future expansion.
TLRY Price Action
TLRY's shares were trading 4.44% higher at $1.76 per share at the time of this writing around noon ET Tuesday.
Related News
- Hemp-Derived Products Like Delta-8 THC Are ‘Here To Stay,’ Says Analyst
- Cannabis Companies Have Missouri’s Governor Beat: Hemp-THC Products Sales Resume As Stricter Controls Replace Sweeping Ban
Image courtesy of Tilray.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!